Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of drug composition in preparation of drugs for preventing salmonella infection in laying hens

A composition, Salmonella technology, applied in application, antibacterial drugs, animal feed, etc., to achieve the effect of eliminating endotoxemia, avoiding food safety problems, and improving defense

Inactive Publication Date: 2018-10-26
LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In order to solve the problems existing in the prior art, the present invention provides the application of a safe, reliable, hormone-free, side-effect-free and drug-residue pharmaceutical composition in the prevention and treatment of Salmonella infection in laying hens, which can be used to purify Salmonella in laying hens. reduce the horizontal transmission of Salmonella in chicken flocks and egg-derived contamination caused by potential endogenous displacement, improve egg quality, and effectively avoid food safety problems caused by egg-derived Salmonella

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of drug composition in preparation of drugs for preventing salmonella infection in laying hens
  • Application of drug composition in preparation of drugs for preventing salmonella infection in laying hens
  • Application of drug composition in preparation of drugs for preventing salmonella infection in laying hens

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The formula of the pharmaceutical composition of the prevention and treatment of laying hen Salmonella infection of the present invention is:

[0023] Gallic tannic acid 20 parts by weight, glycine 10 parts by weight.

[0024] According to the prescription ratio, 20 kg of gallic tannic acid and 10 kg of glycine are weighed and mixed evenly to obtain the pharmaceutical composition for preventing and treating salmonella infection in laying hens.

Embodiment 2

[0026] The formula of the pharmaceutical composition of the prevention and treatment of laying hen Salmonella infection of the present invention is:

[0027] Gallic tannic acid 30 parts by weight, glycine 20 parts by weight.

[0028] According to the prescription ratio, 30 kg of gallic tannic acid and 20 kg of glycine are weighed and mixed evenly to obtain the pharmaceutical composition for preventing and treating salmonella infection in laying hens.

Embodiment 3

[0030] The formula of the pharmaceutical composition of the prevention and treatment of laying hen Salmonella infection of the present invention is:

[0031] Gallic tannic acid 50 parts by weight, glycine 30 parts by weight.

[0032] According to the prescription ratio, 50 kg of gallic tannic acid and 30 kg of glycine are weighed and mixed evenly to obtain the pharmaceutical composition for preventing and treating salmonella infection in laying hens.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of a drug composition in the preparation of drugs for preventing salmonella infection in laying hens, improving egg laying performance of the laying hens, reducing the amount of salmonella in shells and contents of eggs and improving quality of the eggs of the laying hens. The drug composition comprises, by weight, 20-50 parts of gallnut tannic acid and 10-30parts of glycine. The drug composition has the advantages of green safety and no tolerance by taking 'source conditioning' as the core; replacing antibiotics, the drug composition can effectively inhibit and kill salmonella, eliminate endotoxemia caused by bacterial death and release of endotoxin, adjust the body's immune defense, purify salmonella from the laying hens, reduce horizontal spread ofsalmonella and egg-borne contamination caused by potential endogenous displacement of chickens, improve egg laying performance and the quality of the eggs and effectively avoid food safety problems caused by the egg-derived salmonella.

Description

technical field [0001] The invention belongs to the technical field of veterinary medicine, and in particular relates to the application of a pharmaceutical composition in the preparation of medicines for preventing and treating Salmonella infection in laying hens. Background technique [0002] Food safety problems caused by foodborne pathogens have been paid more and more attention, among which, food safety problems caused by Salmonella are an important reason that has plagued the healthy development of the poultry industry for a long time. In the United States, large-scale egg recalls have brought Salmonella infection in eggs into the focus of food safety again. Salmonella can infect eggs through vertical transmission and horizontal transmission. Salmonella infection caused by eggs is considered to be one of the main causes of Salmonella infection in humans. Under normal circumstances, the elderly, children, and some immunocompromised patients are susceptible to Salmonel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23K20/121A23K20/142A23K50/75A61K31/7024A61K31/198A61P31/04
CPCA61K31/198A61K31/7024A23K20/121A23K20/142A23K50/75A61P31/04A61K2300/00
Inventor 崔东安王胜义王磊王慧王玲张康
Owner LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products